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Abstract.  Nerve growth factor (NGF) and brain- 
derived neurotrophic factor (BDNF) are molecules 
which regulate the development and maintenance of 
specific functions in different populations of peripheral 
and central neurons, amongst them sensory neurons of 
neural crest and placode origin.  Under physiological 
conditions NGF is synthesized by peripheral target tis- 
sues, whereas BDNF synthesis is highest in the CNS. 
This situation changes dramatically after lesion of 
peripheral nerves. As previously shown, there is a 
marked rapid increase in NGF mRNA in the nonneu- 
ronal cells of the damaged nerve. The prolonged ele- 
vation of NGF mRNA levels is related to the immi- 
gration of activated macrophages, interleukin-1  being 
the most essential mediator of this effect. 
Here we show that transsection of the rat sciatic 
nerve also leads to a very marked increase in BDNF 
mRNA, the final levels being even ten times higher 
than those of NGF mRNA. However,  the time-course 
and spatial pattern of BDNF mRNA expression are 
distinctly different. There is a continuous slow in- 
crease of BDNF mRNA starting after day 3 post-lesion 
and reaching maximal levels  3-4 wk later.  These dis- 
tinct differences suggest different mechanisms of regu- 
lation of NGF and BDNF synthesis in non-neuronal 
cells of the nerve. This was substantiated by the dem- 
onstration of differential regulation of these mRNAs in 
organ culture of rat sciatic nerve and Schwann cell 
culture. Furthermore, using bioassays and specific anti- 
bodies we showed that cultured Schwann cells are a 
rich source of BDNF- and ciliary neurotrophic factor 
(CNTF)-like neurotrophic activity in addition to NGF. 
Antisera raised against a BDNF-peptide demonstrated 
BDNF-immunoreactivity in pure cultured Schwann 
cells, but not in fibroblasts derived from sciatic nerve. 
B 
RAIN-derived neurotrophic factor (BDNF) l and nerve 
growth factor (NGF) belong to a still growing fam- 
ily of  neurotrophic molecules collectively called neu- 
rotrophins (6, 60). These proteins show a similar basic struc- 
ture reflected by conserved domains arranged around the six 
cysteine residues which seem to be of great importance  in 
determining the three-dimensional  structure  of these mole- 
cules,  a prerequisite  for their biological activity. However, 
BDNF and NGF also show distinctly different variable do- 
mains which determine the different spectra of  their neuronal 
specificity.  Both  BDNF  and  NGF  support  neural  crest- 
derived sensory neurons in the periphery (placode-derived 
sensory neurons are supported only by BDNF and neurotro- 
phin-3 [NT-3])(27, 28, 37). The effects of  different neurotro- 
phins  on DRG neurons  are additive  in vitro  (BDNF  and 
NGE see reference 37; BDNF and NT-3, see reference 28), 
suggesting that the various sub-populations of neurons are 
1. Abbreviations used in this paper: BDNF, brain-derived neurotrophic fac- 
tor; DRG,  dorsal root ganglion; FK,  forskolin; IL-1, intefleukin-1;  NGF, 
nerve growth factor; NT-3, neurotrophin-3. 
supported by different members of the NGF gene family in 
a partly overlapping manner. Under physiological as well as 
culture conditions NGF is produced in target tissues of  mixed 
peripheral nerves, such as skin and iris (4, 7, 13, 14, 20, 21, 
54, 55), whereas BDNF expression has not been detected in 
the periphery, with the exceptions of  lung, heart, and skeletal 
muscle (26, 33, 40) where the cellular site of synthesis re- 
mains to be established. However, in the central nervous sys- 
tem (CNS) expression of BDNF mRNA is more extensive 
including the spinal cord (26, 40, 68).  Therefore, it seems 
reasonable  to  assume  that  DRG  sensory  neurons  obtain 
BDNF via their central processes.  BDNF mRNA has re- 
cently also been detected in DRG neurons  (15, 16). It re- 
mains unclear whether conditions exist where these neurons 
are  supplied  with  BDNF  in  an  autocrine  or  paracrine 
manner. 
NGF  is  not  expressed  to  a  significant  extent  in  non- 
neuronal cells of  adult peripheral nerves (22). However, this 
situation changes dramatically after nerve lesion.  A rapid, 
transient, and massive increase in NGP mRNA occurs in the 
nerve  region  immediately  proximal  to the lesion  and all 
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lowed by a second increase in NGF mRNA which lasts sev- 
eral weeks. The second long-lasting increase is mostly due 
to IL-1 released by macrophages invading the lesioned nerve. 
This can be deduced from the observation that the second in- 
crease of NGF mRNA in vivo coincides with the invasion of 
macrophages at the lesion site (23). An initial rapid increase 
without the subsequent second phase is observed in nerve or- 
gan culture. However, the second increase of NGF mRNA 
observed in vivo can be mimicked by the addition of acti- 
vated macrophages or even recombinant IL-1 to organ cul- 
tures (23,  36), and can be blocked by IL-1 antibodies (36). 
The role played by macrophage-secreted IL-1 is further sup- 
ported by the recent observation that the mouse strain Ola 
(which  is  defective in macrophage invasion into lesioned 
nerves) only shows the rapid immediate increase and a much 
smaller secondary increase in NGF mRNA (9). This smaller 
increase is paralleled by the lower increase in IL-1/3 mRNA 
corresponding  to  the  highly  reduced  invasion of macro- 
phages (24). We have now analyzed the expression of BDNF 
mRNA, BDNF-like activity and the localization of BDNF- 
like immunoreactivity in the transsected peripheral rat nerve 
and in isolated Schwann cells and fibroblasts of  the rat sciatic 
nerve.  As previously shown for NGF,  BDNF  mRNA  in- 
creases to high levels after lesion. However, the time-course 
of the elevation of BDNF mRNA levels is distinctly different 
from that of NGF mRNA. In contrast to NGF mRNA, the 
increase in BDNF mRNA distal to the transsection site is 
monophasic and takes place at a much slower rate, reaching 
maximal levels at approximately four weeks posttranssec- 
tion. The maximal BDNF mRNA levels are about 10 times 
higher  than  those  of NGF  mRNA.  These  observations 
demonstate that different regulatory mechanisms control the 
levels of BDNF and NGF mRNA in the lesioned nerve in 
vivo. Specifically, IL-1 does not alter BDNF mRNA levels 
in explant cultures of sciatic nerve. Moreover, in vitro syn- 
thesis of BDNF is restricted to Schwann cells and the levels 
of BDNF and NGF mRNA in these cells are differentially 
regulated. 
The massive increase in BDNF mRNA in sciatic nerve and 
in isolated Schwann cells is of particular interest in view of 
previous  observations  that  peripheral  nerve  grafts  and 
Schwann cells proved to be conducive for the regeneration 
of central neurons, in particular retinal ganglion cells (31, 
39, 59, 64) and dopaminergic striatal neurons (11, 12, 17, 30, 
62) which are supported by BDNF, but not by NGE 
Materials and Methods 
Materials 
Forskolin  (7~acetoxy-8,13-epoxy-la,6/3,9a-trihydroxylabd-14-ene-11-one); 
ionomycin; phorbol 12-myristate 13-acetate (TPA); 8-bromo-cAMP; and 
Nt-benzoyl-cAMP were purchased from  Sigma Chemical Co.  (Deisen- 
hofen, Germany). Purified porcine I"GF/~I was obtained from British Bio- 
Technology (Oxford, England). Human recombinant IL-1/3 was a generous 
gift of Drs. A. Gronenborn (Max-Planck-Institute for Biochemistry, Mar- 
tinsried, Germany) and P. Wingfield (Biogen/Glaxo, Geneva, Switzerland). 
Recombinant Proteins and Antibodies 
Recombinant mouse NT-3 was produced and purified as described by Gttz 
et  al.  (1992).  Recombinant  mouse  BDNF  was  produced by  the  same 
method. They were generously provided by Y.-A. Barde and R. Kolbeck 
(Max-Planck-Institute for Psychiatry, Department of Neurochemistry, Mar- 
tinsried, Germany).  The biological activity of recombinant BDNF  was 
identical to that of BDNF purified from pig brain (27).  BDNF-peptide 
specific antisera were produced and characterized as previously described 
by Wetmore et al.  (1991).  Briefly,  polyclonal antisera have been raised 
against a  synthetic peptide derived from BDNFI73-1s2. Recombinant rat 
CNTF was a kind gift of M. Sendtner (Max-Planck-Institute for Psychiatry, 
Department of Neurochemistry, Martinsried, Germany) and was produced 
as described  by Masiakowski et al. (1991). The CNTF antiserum was kindly 
provided by M.  Sendtner. It was raised by immunization of rabbits with 
recombinant rat CNTE An IgG fraction was purified on a protein G column 
(Pharmacia Fine Chemicals, Freiburg, Germany) according to the manufac- 
turer's instructions, dialyzed extensively, lyophilized, and used at the indi- 
cated concentrations. 
Surgical Procedures 
Wlstar rats (180-250 g) were ether anaesthetized and a 7-10-mm piece of 
the right sciatic nerve was resected with minimal damage of surrounding 
tissues. No further attempts were made, such as ligation or deflection of the 
proximal stump, to prevent reirmervation of the distal stump. Clips were 
used to close the wound. After indicated times rats were killed by cervical 
dislocation and the nerves dissected according to the scheme presented in 
Fig.  I B and rapidly frozen in liquid nitrogen. 
Cell Culture 
Pieces of adult and newborn rat sciatic nerve (six pieces of 5-mm length) 
were kept in culture (10% FCS, DME) for 3 d with daily changes of media 
as previously described (23, 44). The indicated treatments were started the 
third day. 
Schwann cell cultures were performed as previously described in detail 
by Matsuoka et al.  (1991b).  During selection and expansion of cultures 
cytosine-arabinoside  and forskolin (FK) were used. For a discussion of  pos- 
sible influences of these drugs of Schwarm cell phenotype and NGF mRNA 
expression see Matsuoka et al.  (1991b). 
The dissociation and tissue digestion methods used for Schwann cell cul- 
tures have also been used for fibroblast cultures derived from nerves of 1-3- 
d-old rats. Cytosine-arabinoside selection was however omitted. Such cul- 
tures normally develop into cultures heavily contaminated by Schwann cells 
situated above a fibroblast monolayer. Schwann cells were eliminated from 
these cultures by treatment with 10/~M FK starting the second day in vitro. 
Consistent with previous observations Schwann ceils need, in addition to 
FK and growth factors contained in FCS, a specific substrate, in this case 
poly-lysine, to proliferate (47,  65).  However, fibroblasts from the same 
nerves grow in FK-containing media on plain tissue culture plastic. Seven 
to nine days after initiation of the FK treatment confluent monolayers of 
fibroblasts (characterized by indirect immunofluorescence as described by 
Matsuoka et al., 1991b) (>90% Thy 1.1 positive [OX7 monoclonal], <10% 
S100  positive)  were obtained.  These  were passaged once without FK, 
grown to confluency and used for experiments after at least one additional 
medium change. Thus, they were kept without FK for at least 8 d. 
Northern Blot 
Northern blot analysis of mRNA was performed as previously described in 
detail (20,  44).  Briefly,  total RNA was isolated from cultured cells and 
homogenized tissue by the acid phenol method (10), denatured, and sepa- 
rated on agarose gels, vacuum-blotted to nylon and probed with a NGF 
cRNA probe (44), a BDNF cRNA probe (26) or a Po eDNA probe (34). 
To allow for correction of different extraction efficiencies a 0.5-kb synthetic 
NGF-RNA or BDNF-RNA were included during extraction. Autoradio- 
grams were scanned by laser densitometry. Absolute amounts of specific 
mRNA were calculated from standards analyzed simultaneously on each 
gel.  Values were corrected for differences in extraction etficiencies and 
length of transcripts. The absolute amounts of BDNF mRNA are given for 
the smaller of the two transcripts. 
Bioassays 
The bioassay on dissociated E8 chick ciliary neurons has been described 
previously (29). Initially plated neurons and neurons surviving in the pres- 
ence of samples after 24 h were counted. Results were calculated as given 
in the table legend. Samples tested in this bioassay were cell culture media 
conditioned for 3 d on a confluent layer of Schwann cells cultured as de- 
scribed above. At the time of conditioning these cells had received at least 
three medium changes to FK-free medium. Thus, they had been kept for 
at least 10 d without FK. Conditioned media were centrifuged (400 g) to 
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Cultures used for staining  were either expanded cultures as described above, 
mixed cultures obtained after culturing for 2 d without cytosine-arabinoside 
selection or mixed  cultures obtained by co-culture of purified expanded 
populations  of Schwann cells and sciatic fibroblasts (see above). Cells were 
passaged to poly-lysine-coated glass eoverslips  and cultured for 1-3 d be- 
fore fixation (15 min) at room temperature in 4% PFA, 0.1% picric acid. 
Incubations with antisera serving as first antibodies were performed over- 
night at the indicated dilutions as described (67). To reduce unspecific stain- 
ing 5 % normal horse serum was added to the primary antiserum incuba- 
tions.  Primary antibodies were detected using a  biotinylated anti-rabbit 
antibody (1:100) (Amersham Corp.,  Arlington Heights,  IL) and a strep- 
tavidin-F1TC  or  streptavidinoTexas  Red  conjugate  (1:200)  (Amersham 
Corp.). Epifluorescence  microscopy was performed on a Zeiss axiophot mi- 
croscope (Carl Zeiss, Oberkochen, Germany). Antisera from different rab- 
bits and a protein-A-purified  IgG fraction of one of them have been used 
for the staining experiments. 
Figure 1. (A) BDNF mRNA in different segments of the transsected 
sciatic nerve 17 d after lesion. P, proximal segments; D, distal seg- 
ments.  Labeling  of segments  is  indicated  in B.  (B)  Dissection 
scheme. 
remove cellular debris and frozen until use.  Final dilutions of conditioned 
media in the bioassay are indicated in the table legends. Wells used to assay 
recombinant  proteins and controls received an equal mount of fresh DME, 
10% FCS which was also used for Schwaun cell cultures. 
The bioassay on dissociated chick E8 nodose ganglion neurons was per- 
formed as previously described (37).  Results  were obtained after 72 h of 
culture as described in the table legend.  Conditioned media were prepared 
as detailed for the ciliary neuron bioassay  but without dilution. 
Results 
Effect of  Sciatic Nerve Transsection on BDNF mRNA 
Levels in the Nerve Sheath 
In a first series of experiments we analyzed the expression 
of BDNF mRNA in intact and transsected sciatic nerves of 
adult rats. A 7-10-ram piece of nerve was resected unilater- 
ally and two segments of 5-rnm length proximal and distal 
to  the  lesion  were  used  for the  quantification of BDNF 
mRNA levels at the indicated times after transsection (Fig. 
1 B). Comparisons were made on a wet weight basis. Basal 
levels are below the detection limit (16 fg/mg wet weight). 
Clearly elevated levels of 210 fg/mg wet weight were first 
detected 7 d post-lesion distal to the transsection site (Fig. 
2). This increase in BDNF mRNA level continued until 620 
fg/mg was detected 21  d  post-lesion.  A  much smaller in- 
crease was  observed between day 21-28.  In no case were 
fiber strands bridging the gap between the distal and prox- 
imal  stumps  observed during dissection.  As a  control for 
possible  regeneration,  blots  were reprobed with a  rat Po 
cDNA probe. It is well established that Po mRNA is down- 
regulated in distal parts of transsected peripheral nerves and 
stays at a low level as long as regenerating fibers do not reach 
the distal Schwann cell bands (61). All nerves analyzed more 
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Figure 2.  (A) For comparison, the time course 
of NGF mRNA changes in the first distal seg- 
ment  of the  transsected  rat  sciatic  nerve  is 
shown  (taken  from  reference  17).  (B)  Time 
course of BDNF  mRNA  changes in the first 
distal segment D1  after resection as described 
in  Materials  and  Methods.  Levels  of BDNF 
mRNA  at  day  1  through  day  3  after  lesion 
were below the detection limit (16 fg/mg wet 
weigh0. Average and SD of three independent 
experiments are shown. 
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levels in cultured Schwann cells. Ionomycin was given at 1 t~g/ml 
for the indicated times.  Duplicate samples are shown. 
Figure 3. Comparison of BDNF mRNA and NGF mRNA in new- 
born nerve organ cultures.  (Top) BDNF mRNA; (bottom) NGF 
mRNA. (Standard) NGF recovery standard. (IL-IB) 50 U/ml, 3 h; 
(Ion) ionomycin, 1 #g/ml, 3 h. For each treatment duplicate sam- 
pies axe shown. 
than 14 d after lesion did not contain detectable Po mRNA 
in distal segments (data not shown). 
Interestingly, the  elevation of BDNF  mRNA levels was 
restricted to distal segments and was most pronounced in 
the segment immediately distal to the transsection site (Fig. 
1,4). 
As described for other tissues, BDNF mRNA was detected 
as two bands of 1.5  to  1.7 kb and o04.6  kb.  No additional 
bands were seen. The molar ratio of the small to long tran- 
script was ~3 at all times after lesion (Fig.  1 A). This ratio 
is similar to the one described for other tissues (26,  40). 
Regulation of  BDNF mRNA Levels in Nerve 
Organ Culture 
Since the maximal increase in BDNF mRNA in vivo was not 
reached  before  2  wk  post-lesion  a  regulatory  role  for 
secreted macrophage products is unlikely. As described ear- 
lier,  administration  of II_,-1/3 (which  is  a  major  product 
released by activated macrophages) to nerve organ cultures 
derived from newborn or adult animals resulted in a marked 
increase in NGF mRNA (36, 44). However, this was not ac- 
companied by any change in BDNF mRNA levels (Fig. 3). 
Similar results were obtained in adult nerve organ cultures 
(data not shown). Basal levels of BDNF mRNA in these cul- 
ture systems were clearly detectable and higher than levels 
in intact nerve in vivo. This effect of culturing has also been 
previously  observed  for  NGF  mRNA  levels.  However, 
BDNF mRNA levels in organ culture were not maximal as 
they could be further increased by ionomycin treatment (Fig. 
3). This is in agreement with the data obtained in Schwann 
cell cultures (see below). 
Regulation of  BDNF mRNA in Cultured Schwann 
Cells by Polypeptides and Second Messenger Pathways 
The  analysis  was  extended  to  Schwarm cells  as  the  most 
abundant  non-neuronal  cell  type of the  sciatic  nerve.  As 
reported previously, cultured Schwann cells prepared from 
newborn sciatic nerve constitutively express BDNF mRNA 
(1, 43) (Fig. 4, lanes I and 2, control). This basal expression 
amoun~  to o018 pg/10  ~ cells. Thus cultured Schwann cells 
contain clearly elevated amounts of this mRNA compared to 
BDNF  mRNA  levels  in  intact  nerve.  Administration  of 
ionomycin resulted in a rapid increase of BDNF mRNA lev- 
els (two- to threefold) similar to that found in organ cultures 
(Fig. 5 and Table I). The effect of ionomycin could be further 
potentiated by co-administration of TPA (*10-fold) (Table 
I).  TPA  alone  had  a  small  suppressive  effect on  BDNF 
mRNA levels (Table I). 
Besides the two mRNA transcripts referred to above no ad- 
ditional band was seen.  The ratio of small to long mRNA 
was, again,  o03. 
In agreement with the results reported for nerve organ cul- 
ture no effect of IL-1 was observed (Table I). 
Figure 4.  Regulation of BDNF mRNA in 
cultured Schwann cells by cAME (FK)  for- 
skolin, l0 #M; (DFK) dideoxyforskolin, 10 
#M;  (8-Br) 8-bromo  cAMP, 0.5  raM; 
(6-Ben) N6-benzoyl-cAMP, 0.5 raM; (8-Br) 
6-Ben: combination of both, each 0.5 raM. 
All treatments were done for 3 h. Duplicate 
samples are shown. 
The Journal of Cell Biology, Volume 119, 1992  48 Table L Regulation of  Schwann Cell BDNF mRNA Levels 
by Growth Factors and Signal Transduction Pathways 
Factor added  BDNF mRNA relative to control 
Control  1 
FK  0.33  +  0.06 
TPA  0.7  +  0.17 
IONO  2.7  +  0.36 
IONO  +  FK  0.75  +  0.21 
IONO  +  TPA  9.7  +  1.9 
IL-1/3  0.9  +  0.21 
TGF-/31  0.18  +  0.02 
BDNF mRNA levels of cultured Schwann cells were analyzed by quantitative 
Northern blotting and values (average +  SD of three independent determina- 
tions) are given relative to control levels which were set 1. Factors used: (FK) 
10 t~M, 3 h; (TPA) 100 ng/ml, 3 h; (IONO) ionomycin, 1/~g/ml, 3 h; for com- 
binations the same concentrations were applied for 3 h; (TGF-bl)  1 ng/ml, 
24 h; (IL-1B) recombinant human IL-1/3, 50 U/ml, 3 h. 
Interestingly, FK which is a direct activator of adenylate 
cyclase and induces NGF mRNA in Schwann cells, reduced 
BDNF mRNA levels reproducibly to 33%  of basal levels 
(Fig. 4). Dideoxyforskolin, an analogue of FK which does 
not  activate  adenylate  cyclase,  failed  to  reduce  BDNF 
mRNA.  Furthermore, membrane-permeable derivatives of 
cAMP also elicited a reduction ofBDNF mRNA levels com- 
parable to that seen with FK (Fig. 4).  The effect of cAMP 
elevation by FK could not be suppressed by an inhibitor of 
protein kinase C (H7, 50/~M) nor, remarkably, by an inhibi- 
tor of protein kinase A (H8, 50/~M) (data not shown) (25). 
Forskolin treatment also suppressed the increase of BDNF 
mRNA levels induced by ionomycin (Table I).  Treatment 
of Schwann cells with TGF-/31 which has previously been 
shown to reduce basal NGF mRNA expression (44) also re- 
suited in a clear reduction of BDNF mRNA levels (Table I). 
Fibroblast cultures purified and expanded as described in 
Materials  and  Methods  contained  ~10%  of the  BDNF 
mRNA  levels determined for Schwann cell cultures when 
equal amounts of  total RNA were analyzed (data not shown). 
Neurotrophic Activity in Schwann 
Cell-conditioned Media 
This series of experiments was performed with the goal to 
establish whether the BDNF mRNA levels in Schwann cells 
are reflected by a corresponding production of BDNF-Iike 
activity. Since neither a specific immunoassay nor blocking 
antibodies  for BDNF  are  available,  the  determination of 
BDNF-like activity depended on an appropriate bioassay. 
To evaluate the presence of  cross-reacting neurotrophic ac- 
tivity we initially tested Schwann cell conditioned media in 
an assay using ciliary ganglion neurons. These neurons do 
not respond to BDNF or to NGF (37;  see reference 52 and 
data not shown).  This assay was chosen to investigate the 
presence of CNTE which has a potent neurotrophic activity 
on a  large variety of neurons (see reference 52) and thus 
might  interfere  with  other  bioassays.  Schwann  cell-con- 
ditioned media contained enough CNTF-Iike activity to res- 
cue ~50% of the plated neurons at a 1/10 dilution (Table II). 
A  polyclonai antiserum produced against recombinant rat 
CNTE which completely blocks the effect of 1 ng/ml of re- 
combinant CNTE reduced the survival activity of Schwann 
cell-conditioned media to 15 %. 
Dissociated nodose ganglion neurons of E8 chick were 
Table II. Neurotrophic Activity of  Schwann 
Cell-conditioned Media: Bioassay on E8 Chick 
Ciliary Ganglion Neurons 
Factors added  Percent specific  survival 
SC-CM  54  +  12.9 
SC-CM  +  anti-CNTF,  5/~g/ml  19" 
SC-CM  +  anti-CNTF,  10/~g/ml  13" 
SC-CM  +  anti-CNTF,  20/~g/ml  15  +  2.5 
SC-CM  +  anti-CNTF,  40/zg/ml  11" 
CNTF  93  +  12.7 
SC-CM  +  CNTF  85* 
The assay was performed on dissociated E8 chick ciliary ganglion neurons. 
Surviving cells were counted after 48 h and percentages were calculated as for 
Table III.  Background survival was 0%  in all experiments. If not indicated 
otherwise average :t: SD were calculated from three independent experiments 
assaying three different Schwann cell-conditioned media. 
(SC-CM) Obtained as given in Materials and Methods, used at a final dilution 
of 1/10;  (CNTF)  recombinant rat CNTF,  1 ng/ml; (anti-CNTF) neutralizing 
CNTF antiserum as described. 
* Single value. 
* Average of two independent experiments using two different SC-CM. 
used as a BDNF-sensitive bioassay. In confirmation of  previ- 
ous results (52), recombinant CNTF has a substantial sur- 
vival effect in this assay which can however be blocked by 
CNTF-antiserum (data not shown). Thus anti-CNTF antise- 
rum was added to all samples. Native undiluted conditioned 
media showed high survival activity in this assay,  rescuing 
86%  of all  plated neurons  (Table I/I).  Inclusion of anti- 
CNTF resulted in a  reduction to 53 %  surviving neurons. 
Due  to  the  unavailability of neutralizing  antisera  against 
BDNF it was necessary to use an indirect way to demonstrate 
that  the  remaining  activity,  at  least  in  part,  represented 
BDNF-like  activity.  If  Schwann  cell-conditioned  media 
were to  contain  saturating  concentrations of BDNF,  one 
would predict no increase in survival activity by addition of 
recombinant BDNE Addition of a saturating dose of BDNF 
to anti-CNTF treated samples resulted in only a  small in- 
crease of neuronal survival (Table III). The same concentra- 
tion of  exogenous BDNF alone in the presence of  anti-CNTF 
rescued 37 % of  the plated neurons. Thus the lack of  a distinct 
additional effect of exogenous BDNF suggests that Schwann 
Table IlL Neurotrophic Activity of  Schwann 
Cell-conditioned Media: Bioassay on E8 Nodose Neurons 
Factors added  Percent specific  survival 
SC-CM 
SC-CM  +  anti-CNTF 
SC-CM  +  anti-CNTF  +  BDNF 
anti-CNTF  +  BDNF 
SC-CM  +  anti-CNTF  +  NT-3 
anti-CNTF  +  NT-3 
anti-CNTF  +  BDNF  +  NT-3 
86  +  5.7 
53  +  3.6 
60+5.7 
37  +  9.5 
70+3.2 
34  +  6.4 
63  +  4.9 
The assay was performed on dissociated E8 chick nodose ganglion neurons. 
Surviving cells after 72 h in culture were calculated as a percentage of initially 
plated cells. Survival without added factors has been subtracted (background 
values for the three experiments done were:  l,  10, 2%).  Averages +  SD of 
three independent experiments assaying three different samples of Sehwann 
cell conditioned media are given. Factors added: (SC-CM) Undiluted Schwann 
cell conditioned medium, containing 10%  FCS,  conditioned for 3 d;  (anti- 
CNTF) IgG-fraction of a neutralizing CNTF antiserum at l0 tzg/ml;  (BDNF) 
recombinant  mouse  BDNF,  1  ng/ml;  (NT-3)  recombinant  mouse  NT-3, 
l  ng/ml. Factors were added once and were present throughout the whole cul- 
ture period. 
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like activity which were close to saturation. 
Addition of a  saturating  concentration of recombinant 
NT-3  to anti-CNTF treated conditioned medium samples 
resulted in higher increases of survival activity (Table ~I). 
This percentage is lower than the one achieved by addition 
of NT-3  alone.  This and the fact that Schwann cell-con- 
ditioned media in the presence of neutralizing CNTF anti- 
bodies rescue 16% more neurons than BDNF alone suggests 
that these media contain a factor acting on NT-3 responsive 
neurons. The molecular identity of  this neurotrophic activity 
has not been elucidated. It cannot be excluded that it, at least 
partly, represents NT-3, although preliminary Northern blot- 
ring experiments did not reveal the presence of NT-3 mRNA 
in cultured Schwann cells  (levels were lower than "0250 
fg/106 cells)  (data not shown).  For comparison,  Schwann 
cells cultured as described here contain "05.6 pg of NGF 
mRNA/106  cells  (44)  and  '~18  pg  of BDNF  mRNA/106 
cells (see above). 
Intracellular Localization of  BDNF-like 
Immunoreactivity 
In an attempt to provide more direct evidence for the pres- 
ence of BDNF protein in Schwann cells we used antisera 
raised against a peptide sequence contained in BDNF for im- 
munostainlng studies of cultured Schwann cells. These an- 
tisera  have  previously been  extensively characterized by 
Wetmore et al.  (1991). As our Northern blot analysis of 
fibroblasts derived from newborn sciatic nerves showed only 
very little specific BDNF mRNA, we used mixed cultures 
of Schwarm cells and fibroblasts to provide an internal con- 
trol of staining specificity. 
These experiments revealed clear and evenly distributed 
staining of Schwarm cells (Fig. 6 A). Most of the fiat large 
cells present in the cultures were identified as Thyl positive 
and S100  negative in  separate immunostainings and thus 
probably represented fibroblasts. In most ('090%) of these 
cells no staining could be detected. However, ,o10% of the 
flat cells showed a  staining comparable in intensity to the 
staining of Schwann cells (Fig. 7 A). Closer examination of 
the staining revealed an exclusively extranuclear signal in 
both positive cell types (Figs. 6 A and 7 A). In many cells 
the most intensive staining was restricted to the perinuclear 
area (Fig. 6 A). However,  a faint but clear signal was also 
detected in Schwann cell processes. At higher magnification 
the staining in Schwann cells appeared granular (Fig. 6 C). 
Antisera obtained from two different rabbits,  and an IgG 
fraction purified from one of them, gave similar results. 
Discussion 
Comparison of the Expression Pattern of  BDNF 
mRNA and NGF mRNA after Nerve Lesion 
The data presented provide evidence that synthesis of BDNF 
is upregulated after peripheral nerve lesion in non-neuronal 
cells of the nerve sheath. A similar augmentation of synthe- 
sis has previously been reported for NGF (22).  However, 
there are striking differences between the two neurotrophins 
regarding the time course, the magnitude of the response and 
its localization. The biphasie increase in NGF mRNA is 
characterized by a  first very rapid and transient increase 
peaking at "06 h  after lesion and a  second prolonged one 
starting around 2 to 3 d after lesion (22). In contrast, there 
is no detectable increase in BDNF mRNA for up to three 
days after lesion. Thereafter, amounts of BDNF mRNA rose 
slowly and reached maximal levels after 2 wk after lesion. 
There  is  good evidence that macrophage-derived IL-1  is 
responsible for the second phase of the NGF mRNA in- 
crease. Since a maximum of macrophage invasion and acti- 
vation at the lesion site occurs between day 2 and 6 after 
transsection (8, 46), products of stimulated macrophages are 
not likely to play a role in the delayed and prolonged increase 
of BDNF mRNA. This notion is supported by the lack of 
effect of IL-1 on BDNF mRNA levels in nerve organ cultures 
which  are  a  reasonable  model  for  IL-I-mediated NGF 
mRNA regulation (23). 
Interestingly, high levels of BDNF mRNA are found al- 
most  exclusively  in  distal  nerve  pieces.  In  contrast,  a 
significant increase in NGF mRNA has been detected in the 
nerve stump immediately proximal to the lesion site which 
is also invaded by macrophages. Therefore this difference in 
the localization of trophic factor again might be explained by 
macrophage-independent BDNF induction. 
Additionally, a biphasic production of neurotrophic activ- 
ity has been previously described for rat DRG neurons by 
Windebank and Poduslo (1986).  Distal nerve pieces  dis- 
sected 3 to 7 d after transsection produce an activity which 
can be partly blocked by antisera to NGF. A second phase 
of production of neurotrophic activity which could not be 
blocked by these antisera was observed in pieces undergoing 
degeneration for 2 to 4 wk. This observation might be ex- 
plained by the initial rapid release and production of NGF 
(22) and CNTF (41, 53, 69) and the delayed production of 
BDNF described here. It is unlikely that CNTF is responsi- 
ble for the second phase since nerve lesion leads to a rapid 
decrease in CNTF mRNA and, with some delay, CNTF pro- 
tein (53).  Nerve pieces distal to a crush lesion or transsec- 
tion have also been shown to produce survival activity for 
retinal ganglion cells (59). Retinal ganglion cells of  adult rats 
after optic nerve lesion (59)  and of embryonic rats (31) in 
culture can be kept alive by BDNF. The activity in sciatic ex- 
udate was not additive to BDNF suggesting that it was identi- 
cal to BDNF (59). CNTF does not affect the survival of cul- 
tured embryonic retinal ganglion cells (31). 
Under normal conditions both NGF and BDNF mRNA 
are barely detectable in intact sciatic nerve.  However,  the 
levels of both mRNAs are up-regulated after nerve lesion. 
The maximal tenfold higher levels of BDNF mRNA as com- 
pared to NGF mRNA indicate that cells of the nerve sheath 
under  the  appropriate  circumstances  can be  a  very  rich 
source of BDNF. This is also interesting in view of the fact 
that BDNF has been regarded primarily as a centrally pro- 
duced neurotrophin and that expression of BDNF mRNA 
outside the CNS has initially been detected in only two pe- 
ripheral organs (lung and heart) (26, 33, 40) and later also 
in a subpopulation of DRG neurons (15, 16). BDNF mRNA 
has not been detected in adult mouse skin (40).  Recently, 
however, constitutive levels of BDNF mRNA have been de- 
scribed in poly-A  + RNA of newborn rat skin (1). The rea- 
sons for this discrepancy are unclear. Species and age differ- 
ences, as well as the amount of RNA analyzed ('0 eightfold 
more in the study by Acheson et al., 1991), may be respon- 
sible. 
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Schwann cells (small arrows) show mainly perinuclear staining. Nuclei are spared. (b, phase contras0 One fibroblast (long arrow) is not 
stained in a. (c, epifluorescence) At higher magnification staining of  Schwann cells appears as diffuse granules extending into cell processes. 
Whole antiserum diluted 1:500 was used. Bars: (a and b) 50 #m; (c) 25 #m. 
Regulation of  BDNF mRNA and NGF mRNA 
in Cultured Schwann Cells 
Our data clearly demonstrate a differential regulation of the 
levels  of  BDNF  mRNA  and  NGF  mRNA  in  cultured 
Schwann cells and nerve organ cultures. In contrast to the 
six- to ten-fold increase in NGF mRNA levels induced by 
elevation of intracellular cAMP (44), a significant reduction 
of basal  as  well  as  ionomycin  induced  levels  of BDNF 
mRNA is observed in cultured Schwann cells. This finding, 
together with the differential regulation observed in organ 
culture and the differences in the time course and localization 
of  expression  after  lesion,  suggests  that  fundamentally 
different mechanisms regulate the expression of these struc- 
turally related proteins. It is, however, not clear whether a 
situation analogous to cAMP elevation in culture occurs in 
vivo during degeneration/regeneration or development and 
what the extracellular signals mediating such changes might 
be. Stimulation of  another set ofkinases (particularly protein 
kinase C) by TPA had a weak suppressive effect on BDNF 
mRNA levels. A stronger suppressive effect has previously 
been observed on NGF mRNA levels (44). TGF-fll exerts 
a  strong  suppressive effect on basal  as  well as  stimulated 
NGF  mRNA  levels  (44)  and  a  similar  effect on  BDNF 
mRNA  expression.  Whether kinases activated by phorbol 
esters or signal transduction pathways activated by TGF-/~  1 
might play a role in down-regulation of neurotrophin expres- 
sion after regeneration, or in the maintenance of low neu- 
rotrophin levels in  intact nerves deserves further investi- 
gation. 
Release of Neurotrophic Activities by Cultured 
Schwann Cells 
An important question is  whether Schwann cells produce 
and  release active BDNF  protein.  The tools  available to 
study this question are still limited. With the discovery of ad- 
ditional neurotrophins acting on partly overlapping sets of 
target neurons, it is difficult to assure monospecificity of any 
bioassay used. Furthermore, neutralizing antibodies against 
BDNF are not yet available. We chose to assay survival of 
E8 chick nodose ganglion neurons since these neurons are 
responsive to BDNF, which may be released from Schwann 
cells after lesion, and are not responsive to NGF which is 
also present in Schwann cell-conditioned media (3, 44, 49). 
This bioassay does not distinguish between BDNF and NT-3, 
which support survival of these neurons in an additive fash- 
ion. Additionally, E8 chick nodose neurons also respond to 
CNTF (52) which is known to be expressed in sciatic nerve 
and in Schwann cells in vivo as well as in vitro (35, 48, 53, 
56,  57).  Therefore we quantified CNTF-Iike bioactivity in 
Schwann  cell-conditioned media.  We  were  surprised  to 
Meyer et al. Synthesis of BDNF in the PNS  51 Figure 7. Immunolocalization of BDNF in primary 
mixed cultures  after 2 d  in vitro.  (a,  epifluores- 
cence) All Schwann cells (small arrows) are stained 
mainly in the perinuclear region. Additionally, a flat 
long cell (long arrow) displays also mainly perinu- 
clear staining. In both cases nuclei are spared. (b, 
phase contrast) Whole antiserum diluted 1:500 was 
used. Bar, 50 #m. 
detect a  relatively high rate of survival of ciliary ganglion 
neurons, indicating a strong CNTF-like activity. The eDNA- 
derived amino acid sequence of CNTF does not provide evi- 
dence for an aminoterminal signal sequence and CNTF is 
not released from transfected cells (35, 57). Thus CNTF is 
not thought to be secreted from cells. Furthermore, cultured 
Schwann cells express relatively low levels of CNTF mRNA 
as compared to astrocytes (57). These apparent discrepan- 
cies can be reconciled by the fact that the CNTF protein is 
relatively stable (53) and that high amounts of CNTF-like 
neurotrophic activity have been detected in lysates of cul- 
tured Schwann cells. Leakage from a small number of cells 
which are either damaged or are undergoing transient mem- 
brane disturbances might be  sufficient to explain the ob- 
served survival activity. However, it cannot be excluded that 
CNTF is released via an aitemative mechanism.  Schwann 
cell conditioned media appear to contain additional neuro- 
trophic activity for ciliary neurons which cannot be blocked 
by the CNTF-neutralizing antiserum. The molecule respon- 
sible for this effect  is unknown so far. NGF and BDNF which 
are synthesized by Schwann cells are not active on ciliary 
neurons. 
The release  of CNTF-Iike activity  by cultured  Schwann 
cells  has not  been discussed in a recent  study (1),  wherein 
a polyclonal  antiserum against  mouse NGF  was shown to 
substantially reduce survival activity of Schwann cell-con- 
ditioned media measured on dissociated  chick El0 DRG 
neurons. This reduction was interpreted as a cross-reactivity 
of  the antiserum with BDNF-like molecules. Spinal ganglion 
neurons of this age are, however, responsive to CNTF (5) 
and the presence of CNTF-hke activity in supernatants of 
Schwann cells cultured under different conditions has been 
demonstrated (45, 63, and the present study). Thus it is not 
clear whether particular culture conditions can account for 
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NGF-antiserum used may have effects in addition to the ones 
discussed by the authors.  The chick nodose ganglion  assay 
used in the present study for the detection of BDNF is highly 
sensitive to CNTE Application of recombinant CNTF sup- 
ports the survival of at least 40% of the plated neurons (52). 
Treatment of Schwann cell conditioned media with neutraliz- 
ing anti-CNTF antibodies again demonstrated the effect of 
CNTF-like molecules in this  assay. For these reasons, we 
decided to routinely include anti-CNTF antibodies in all no- 
dose bioassays at a concentration high  enough to reliably 
block 1 ng/ml of recombinant rat CNTE The data obtained 
in the nodose bioassay are consistent with the assumption 
that  Schwann  cells  secrete  nearly  saturating  amounts  of 
BDNF-like activity.  Recently,  the effects of Schwann  cell 
conditioned media on the survival of El0 DRG neurons and 
on  neurite  outgrowth  from retinal  explants  has been de- 
scribed which are in agreement with the present results (1). 
Others  have  also  described  neurotrophic  activities  of 
Schwann cell-conditioned media which could not be neutral- 
ized by NGF antisera.  However, again the assay systems used 
did not exclude interference by CNTF (3, 45, 49, 63, 70). 
Localization of  BDNF-like Immunoreactivity in 
Cultured Schwann Cells 
Immunostaining  was used to provide further evidence for the 
presence of BDNF in Schwann cells. The homogenous stain- 
ing of Schwann cells in pure or mixed cultures  suggests that 
at least in culture all  Schwann  cells contribute to BDNF 
production. There seems to be a second cell type present at 
low abundance which is capable of synthesizing or internal- 
izing  BDNF-immunoreactive material.  Sciatic  fibroblasts, 
however, do not show detectable immunostaining.  This find- 
ing is in agreement with the amounts of BDNF mRNA found 
in cultured sciatic fibroblasts which are so low that they can 
easily  be  explained  by  the  presence  of  contaminating 
Schwann  cells.  This  is  in  contrast  to  Northern  blotting 
results obtained by others in cultures of rat dermal fibro- 
blasts  (1). These  discrepancies  might  be  due  either  to 
differential  expression of BDNF in various fibroblast sub- 
populations or to contaminating  cell types. 
It is interesting  to note that we detected an exclusively cy- 
toplasmic  immunoreactivity  in  Schwann  cells.  This  is in 
contrast to the observations made on BDNF-synthesizing 
neurons  in  the CNS  (67).  Although  the significance  and 
structural  basis of a potential  nuclear localization  of BDNF 
are not known, this finding demonstrates that nuclear local- 
ization is not an inevitable consequence of BDNF synthesis. 
We conclude that there is good evidence that  Schwann 
cells in culture and in lesioned peripheral nerves produce 
and secrete two different structurally related neurotrophins, 
NGF  and  BDNE  Production  of neurotrophins  might  be 
beneficial for regenerating  neurons. Although both neurotro- 
phins  act  on  spinal  ganglion  neurons  their  synthesis  is 
differentially  regulated in the nerve sheath,  suggesting that 
the  requirements  for neurotrophins  change  with  ongoing 
regeneration.  It has been suggested that reexpression of the 
low affinity  NGF receptor (p75) on Schwann  cells in de- 
generating  axons plays a role in the accumulation  and pre- 
sentation of NGF to regenerating  axons (58). However, both 
NGF and BDNF bind to p75 (50).  Considering the much 
slower dissociation from p75 of BDNF as compared to NGF 
(50), and the high concentrations of BDNF produced after 
nerve lesion, it is more lilcely that BDNF rather than NGF 
is being presented to regrowing  axons. 
Our results may partially explain the beneficial effects of 
peripheral nerve or Schwarm cell grafts in CNS lesions. Such 
grafts allow partial regeneration and survival of retinal gan- 
glion cells after optic nerve transsection (39, 64), regrowth 
of cholinergic  fibers after fimbria-fomix lesions (19, 32, 66) 
and seem to support mesencephalic grafts (12, 17, 62). This 
interpretation  is in agreement with in vitro studies showing 
that BDNF supports embryonic (3I) and adult retinal  gan- 
glion cells (59), embryonic cholinergic (2), and dopaminer- 
gic neurons (30). Hence the success of these grafts might be 
explained by the combination of a permissive substrate (51) 
with an appropriate neurotrophic factor(s). 
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